What is the potential for using monoclonal antibodies in multiple myeloma?
What is the potential for using monoclonal antibodies in multiple myeloma?
Expert discussion on current experience with monoclonal antibodies in multiple myeloma
ECC 2015: Editor's highlights
Roundtable discussion on CLL: Expert insights from the iwCLL congress
First ‘targeted’ treatment for small cell lung cancer shows promise
Mantle cell lymphoma current treatment practices
Examining NSCLC responses to durvalumab monotherapy
ECC 2015 scientific highlights
Atezolizumab limits disease progression for metastatic urothelial bladder cancer
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise
Multi-peptide vaccine for kidney cancer fails to improve survival